Axel Bouchon, head of
Leaps by Bayer
Bayer
The technology industry is becoming increasingly
embedded into the world of life sciences.
Axel Bouchon, who heads up Leaps by Bayer, an
organization within Bayer focused on finding and funding
breakthroughs, said he expects disruption of the healthcare
industry within the decade to come from the intersection of
tech and biotech.
"The potential of how biophysical data could be
combined with data management will revolutionize the
pharmaceutical industry and all of life sciences," Bouchon
said.
It likely won't be a case of just bringing the two
industries together, he said. It'll take a new group of people
that's able to think differently.
Major
tech companies are eyeing the healthcare world. And the
pharmaceutical industry is starting to take note.
"The true disruption of the next five to 10 years will come at
the interface of tech and biotech," Axel Bouchon, head of
Leaps by Bayer, told Business Insider.
"The potential of how biophysical data could be combined with
data management will revolutionize the pharmaceutical industry
and all of life sciences," he said. "And interestingly, nobody on
the tech side nor on our side has the solution."
Leaps by Bayer is an organization within the life sciences and
pharmaceutical company that's focused on finding and funding what
Bouchon described as "fundamental breakthroughs that really
change and cure."
Carsten Brunn, head of pharmaceuticals in the Americas at Bayer,
told Business Insider he's already started seeing the influence
of technology in his work. For example, machine learning is
helping companies better pinpoint which leaders within healthcare
they might want to work with on a particular disease area or
product launch.
Ultimately, Bouchon hopes, this intersection of biotech and tech
will benefit patients.
"What I would dream of is, if there's a cancer patient entering a
clinic, he or she should have data on hand for him or herself.
Believe me this is hardly possible," Bouchon said. Right now,
there is a lot of data out there collected about patients that
could potentially help. The problem is, that information isn't
exactly the easiest to use.
For now, though, something's still missing that's keeping the
healthcare world from being disrupted.
"I believe that someone will just realize that both sides miss
fundamental expertise," Bouchon said. To fix that, it likely
won't be a case of just bringing the two industries together —
it'll take a new group of people that's able to think
differently, he said.
Source link
No comments:
Post a Comment